CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.080
-0.060 (-1.91%)
At close: Jul 17, 2026, 4:00 PM EDT
3.052
-0.028 (-0.90%)
After-hours: Jul 17, 2026, 7:58 PM EDT
CervoMed Employees
CervoMed had 15 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$139,268
Profits / Employee
-$2,002,433
Market Cap
41.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 0 | - |
| Dec 31, 2024 | 15 | 7 | 87.50% |
| Dec 31, 2023 | 8 | 4 | 100.00% |
| Mar 31, 2023 | 4 | - | - |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 118 |
| PDS Biotechnology | 21 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
| Apollomics | 14 |
| Nutriband | 13 |
| Hyperion DeFi | 9 |
| Dogwood Therapeutics | 8 |
CRVO News
- 4 days ago - CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB) - GlobeNewsWire
- 9 days ago - CervoMed completes enrollment in neflamapimod study - TheFly
- 9 days ago - CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia - GlobeNewsWire
- 12 days ago - CervoMed registers to sell 10.08M shares of common stock for holders - TheFly
- 12 days ago - CervoMed Registration statement: Registration filing - Filings
- 12 days ago - CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026 - GlobeNewsWire
- 26 days ago - CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - CervoMed announces $10M registered direct offering priced at-the-market - TheFly